The Premium Business Information Source™

  

 

Proximagen Neuroscience plc Hodgkin Building, Guy's Campus King's College London London, SE1 1UL United Kingdom URL: http://www.proximagen.com Primary Symbol & Exchange: PRX - Common stock - London Industry: Health Care +  SIC Industry Code: 8069 - Specialty Hospitals, Except Psychiatric +  NAICS Industry Code: 622310 - Specialty (except Psychiatric and Substance Abuse) Hospitals Thomson Financial Business Description: The Group's principal activity is discovering and developing therapeutic treatments for neurodegenerative disease. The Group's operation focuses on Parkinson's diseases and Alzheimer diseases. It provides expertise at the earliest concept stages of research planning as consultants to industry and as advisers through to proof-of-concept and clinical evaluation. It also offers advisory board services, access to experts in all areas of neurology and full consultancy services to the pharmaceutical and biotech industry. The Group also offers evaluation of molecules in cell-based models of neurodegeneration and neuroinflammation that allow rapid evaluation of mechanism-based concepts. Its sales are made in the United States of America, Europe and Japan. Alacra Alerts:    Receive alerts on the latest reports on Proximagen Neuroscience plc Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:

Sorry, no results found in this category

Search for more premium content on Proximagen Neuroscience plc

Copyright © 2009 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.